Core Laboratories N.V.’s (CLB) Buy Rating Reaffirmed at Royal Bank Of Canada

Royal Bank Of Canada reiterated their buy rating on shares of Core Laboratories N.V. (NYSE:CLB) in a research note published on Friday, September 1st. Royal Bank Of Canada currently has a $115.00 price target on the oil and gas company’s stock.

CLB has been the subject of several other research reports. ValuEngine downgraded shares of Core Laboratories N.V. from a hold rating to a sell rating in a report on Friday, September 1st. Zacks Investment Research downgraded shares of Core Laboratories N.V. from a hold rating to a strong sell rating in a report on Monday, July 17th. BidaskClub downgraded shares of Core Laboratories N.V. from a hold rating to a sell rating in a report on Monday, July 31st. UBS AG reissued a neutral rating and issued a $110.00 price target (down from $125.00) on shares of Core Laboratories N.V. in a report on Wednesday, July 26th. Finally, Morgan Stanley cut their price target on shares of Core Laboratories N.V. from $130.00 to $125.00 and set an overweight rating for the company in a report on Monday, August 7th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus price target of $113.58.

Core Laboratories N.V. (NYSE CLB) opened at 96.88 on Friday. The stock has a market capitalization of $4.28 billion, a price-to-earnings ratio of 59.44 and a beta of 1.60. The company’s 50-day moving average is $93.15 and its 200 day moving average is $104.31. Core Laboratories N.V. has a one year low of $86.55 and a one year high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last announced its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The company had revenue of $163.90 million during the quarter, compared to the consensus estimate of $168.23 million. During the same quarter in the previous year, the company posted $0.35 earnings per share. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. Equities analysts expect that Core Laboratories N.V. will post $2.00 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This article was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://ledgergazette.com/2017/09/17/core-laboratories-clb-receives-buy-rating-from-royal-bank-of-canada.html.

Institutional investors have recently made changes to their positions in the business. Parallel Advisors LLC boosted its position in Core Laboratories N.V. by 33.4% during the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock worth $101,000 after purchasing an additional 223 shares during the period. Quantbot Technologies LP bought a new stake in shares of Core Laboratories N.V. in the first quarter valued at approximately $106,000. Advisory Services Network LLC bought a new stake in shares of Core Laboratories N.V. in the first quarter valued at approximately $118,000. FNY Managed Accounts LLC bought a new stake in shares of Core Laboratories N.V. in the first quarter valued at approximately $123,000. Finally, The Manufacturers Life Insurance Company boosted its position in shares of Core Laboratories N.V. by 63.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after acquiring an additional 439 shares during the period.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply